Welcome to the Brain Institute of America, LLC.

The Brain Institute of America, LLC was formed in 2017 with the goal of developing biomarkers for brain diseases and brain cancer. The goal is to develop effective biomarkers for those with chronic neurologic disorders as well as malignancies of the brain. The Institute is specifically focused on noncoding RNAs, a type of molecule that operates by regulating gene function. We have identified several noncoding RNAs that are highly expressed in brain tissue, and The Institute is pursuing those entities for biomarker development.

The Institute is a dedicated biomedical research company with standard laboratory equipment, housed in a state of the art facility. Currently we are in Phase I development which is geared towards developing biomarkers for clinical use. In phase II, curated biomarkers will be commercialized into a product for clinical testing and use.


Please click here for our new virtual Brain Cancer Walk-a-thon